25
Participants
Start Date
December 31, 2011
Primary Completion Date
December 31, 2015
Study Completion Date
May 31, 2016
Vorinostat, Lenalinomide and Dexamethasone
"Vorinostat: 400 mg po days 1-7 and 15-21 Lenalidomide: 25 mg po days 1-21~\* Lenalidomide dose for patients with renal impairment (CrCL\<50ml/min) has be dose adjusted according to package insert~Dexamethasone: 40mg po days 1, 8, 15 and 22 for patients aged less than 75 years, 20mg for those aged 75 years and above"
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Merck Sharp & Dohme LLC
INDUSTRY
Hackensack Meridian Health
OTHER